Synthesis and cytotoxic activity of N,N-bis-{3-[N-(4-chlorobenzo[g]-phthalazin-1-yl)]aminopropyl}-N-methylamine: a new potential DNA bisintercalator-Reference-Cited by-同舟云学术

Synthesis and cytotoxic activity of N,N-bis-{3-[N-(4-chlorobenzo[g]-phthalazin-1-yl)]aminopropyl}-N-methylamine: a new potential DNA bisintercalator

Published:2003-05 Issue:10 Volume:11 Page:2143-2148
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Rodrı́guez-Ciria Marinela,Sanz Ana M,Yunta Maria J.R,Gomez-Contreras Fernando,Navarro Pilar,Fernandez Isabel,Pardo Mercedes,Cano Carmen

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference40 articles.

1. Denny, W. A.; Baguley, B. C.; Cain, B. F.; Waring, M. J., In Mechanism of Action of Anticancer Drugs. Neidle, S., Waring, M. J. Eds.; McMillan: London, 1983.

2. Intercalators as Anticancer Drugs

3. Interactions of molecules with nucleic acids. VI. Computer design of chromophoric intercalating agents

4. Mitoxantrone

5. Anthracyclines and Anthracenedione-Based Anticancer Agents;Lown,1988

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, Characterization and Antifungal Evaluation of Novel Pyridazin-3(2H)-One Derivatives;Polycyclic Aromatic Compounds;2022-02-27

2. Genotoxicity evaluation of a new phthalazine substituted β-lactam derivative in human lymphocytes;Anais da Academia Brasileira de Ciências;2022

3. Donor–Acceptor Cyclopropanes as an Expedient Building Block Towards the Construction of Nitrogen‐Containing Molecules: An Update;Advanced Synthesis & Catalysis;2020-04-08

4. A Family of Heterocyclic Naphthalene Diimide (NDI) Analogues: Comparing Parent Isoquinoline Diimides and Phthalazine Diimides with NDI;ChemPlusChem;2019-10

5. Design, Synthesis, and Pharmacological Assay of Novel Compounds Based on Pyridazine Moiety as Potential Antitumor Agents;Journal of Heterocyclic Chemistry;2019-08-12